Trial Profile
A phase I trial to investigate CAM-2047
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions
- 03 Nov 2017 New trial record